Kiora Pharmaceuticals, Inc. (KPRX)
NASDAQ: KPRX · Real-Time Price · USD
3.270
+0.050 (1.55%)
Dec 20, 2024, 4:00 PM EST - Market closed
Kiora Pharmaceuticals Market Cap
Kiora Pharmaceuticals has a market cap or net worth of $9.81 million as of December 20, 2024. Its market cap has increased by 133.63% in one year.
Market Cap
9.81M
Enterprise Value
-19.15M
1-Year Change
133.63%
Ranking
Category
Stock Price
$3.27
Market Cap Chart
Since February 13, 2015, Kiora Pharmaceuticals's market cap has decreased from $38.90M to $9.81M, a decrease of -74.77%. That is a compound annual growth rate of -13.04%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 20, 2024 | 9.80M | 145.00% |
| Dec 29, 2023 | 4.00M | 2.56% |
| Dec 30, 2022 | 3.90M | -79.58% |
| Dec 31, 2021 | 19.10M | -16.23% |
| Dec 31, 2020 | 22.80M | -37.36% |
| Dec 31, 2019 | 36.40M | 80.20% |
| Dec 31, 2018 | 20.20M | 9.78% |
| Dec 29, 2017 | 18.40M | 17.95% |
| Dec 30, 2016 | 15.60M | -25.71% |
| Dec 31, 2015 | 21.00M | -46.02% |
View and export this data all the way back to 2015.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Evoke Pharma | 10.48M |
| Zhongchao | 10.41M |
| China Jo-Jo Drugstores | 10.26M |
| Can-Fite BioPharma | 10.09M |
| Aptose Biosciences | 9.95M |
| Mobile-health Network Solutions | 9.75M |
| Cellectar Biosciences | 9.70M |
| Indaptus Therapeutics | 9.56M |